- Nachrichtendetail
-
25.06.2024 14:17:59 - dpa-AFX: *ABBVIE RECEIVES FDA COMPLETE RESPONSE LETTER FOR ABBV-951 IN PARKINSON'S DISEASE TREATMENT
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
ABBVIE | A1J84E | NYSE | 163,840 | 03.07.24 03:00:53 | -2,120 | -1,28% | 163,010 | 164,350 | 166,090 | 163,840 |
